Chemistry Professor Wenbin Lin part of $1M CRF team science initiative to target lethal lung cancer

A $1 million gift from the Cancer Research Foundation (CRF) is mobilizing a team of renowned University of Chicago physicians and scientists to mount an all-out attack on a deadly lung cancer and fuel advances in cancer care more generally. Bringing together leaders in cancer research and care, clinical trials, immunology, drug development, nanotechnology, computation, genomics, and pathology, the three-year initiative encompasses five projects that collectively will drive toward game-changing targeted treatments for small cell lung cancer (SCLC), which each year strikes approximately 30,000 people in the United States alone and is almost uniformly fatal.

Read more